ARTICLE | Clinical News
Virend SP-303 topical anti-viral: Began a Phase II trial.
January 3, 1994 8:00 AM UTC
Shaman Pharmaceuticals Inc. (SHMN), South San Francisco Product: Virend SP-303 topical anti-viral Indication: Recurrent herpes infection in immunocompromised patients Status: Began a Phase II trial of...